default author photo

Hailong Chen

Guangzhou Medical University

SCHOLARLY PAPERS

1

DOWNLOADS

65

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Immune Checkpoint Inhibitors, Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib or Bevacizumab in Unresectable Hepatocellular Carcinoma: A Retrospective, Multi-Center, and Propensity Score Matching Study

Number of pages: 30 Posted: 16 Jul 2024
Zhicheng Lai, Yujie Xu, Hailong Chen, Anna Kan, Zichao Wu, Qijiong Li, Minqiang Lu, Wei Wei, Yao-Jun Zhang, Minshan Chen, Minke He, Xu Li and Ming Shi
Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Guangzhou First People's Hospital, Guangzhou Medical University, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Guangzhou First People's Hospital, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China and Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China
Downloads 65 (924,743)

Abstract:

Loading...

Hepatocellular carcinoma, lenvatinib, bevacizumab, combination therapy, conversion resection